161 related articles for article (PubMed ID: 15881330)
21. Reversal of multidrug resistance to epirubicin by cyclosporin A in liposomes or intralipid.
Lo YL; Liu FI; Yang JM; Cherng JY
Anticancer Res; 2001; 21(1A):445-50. PubMed ID: 11299776
[TBL] [Abstract][Full Text] [Related]
22. Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats.
Shahiwala A; Misra A
J Pharm Pharmacol; 2006 Jan; 58(1):19-26. PubMed ID: 16393460
[TBL] [Abstract][Full Text] [Related]
23. Development of chitosan-coated liposomes for sustained delivery of tamarind fruit pulp's extract to the skin.
Phetdee M; Polnok A; Viyoch J
Int J Cosmet Sci; 2008 Aug; 30(4):285-95. PubMed ID: 18713075
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-coated liposomes for delivery to lungs by nebulisation.
Zaru M; Manca ML; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2009 Jun; 71(1):88-95. PubMed ID: 19201583
[TBL] [Abstract][Full Text] [Related]
25. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
Kamei N; Morishita M; Ehara J; Takayama K
J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
[TBL] [Abstract][Full Text] [Related]
26. The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer.
Degim Z; Unal N; Eşsiz D; Abbasoglu U
Life Sci; 2004 Oct; 75(23):2819-27. PubMed ID: 15464833
[TBL] [Abstract][Full Text] [Related]
27. Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats.
Zheng Y; Qiu Y; Lu MF; Hoffman D; Reiland TL
Int J Pharm; 1999 Aug; 185(1):83-92. PubMed ID: 10425368
[TBL] [Abstract][Full Text] [Related]
28. Formation of biopolymer-coated liposomes by electrostatic deposition of chitosan.
Laye C; McClements DJ; Weiss J
J Food Sci; 2008 Jun; 73(5):N7-15. PubMed ID: 18577008
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers.
Beck RC; Pohlmann AR; Hoffmeister C; Gallas MR; Collnot E; Schaefer UF; Guterres SS; Lehr CM
Eur J Pharm Biopharm; 2007 Aug; 67(1):18-30. PubMed ID: 17317124
[TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization, and biodistribution study of technetium-99m -labeled leuprolide acetate-loaded liposomes in Ehrlich ascites tumor-bearing mice.
Arulsudar N; Subramanian N; Mishra P; Chuttani K; Sharma RK; Murthy RS
AAPS PharmSci; 2004 Feb; 6(1):E5. PubMed ID: 15198506
[TBL] [Abstract][Full Text] [Related]
31. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
32. Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion.
Zheng JY; Fulu MY
Int J Pharm; 2006 Jan; 307(2):209-15. PubMed ID: 16300912
[TBL] [Abstract][Full Text] [Related]
33. A new interpretation of salicylic acid transport across the lipid bilayer: implications of pH-dependent but not carrier-mediated absorption from the gastrointestinal tract.
Takagi M; Taki Y; Sakane T; Nadai T; Sezaki H; Oku N; Yamashita S
J Pharmacol Exp Ther; 1998 Jun; 285(3):1175-80. PubMed ID: 9618420
[TBL] [Abstract][Full Text] [Related]
34. Comparison of different intestinal epithelia as models for absorption enhancement studies.
Legen I; Salobir M; Kerc J
Int J Pharm; 2005 Mar; 291(1-2):183-8. PubMed ID: 15707745
[TBL] [Abstract][Full Text] [Related]
35. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
36. Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
Werle M; Takeuchi H
Int J Pharm; 2009 Mar; 370(1-2):26-32. PubMed ID: 19073243
[TBL] [Abstract][Full Text] [Related]
37. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
Hintzen F; Perera G; Hauptstein S; Müller C; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2014 Sep; 472(1-2):20-6. PubMed ID: 24879935
[TBL] [Abstract][Full Text] [Related]
38. Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).
Degim Z; Mutlu NB; Yilmaz S; Eşsiz D; Nacar A
Pharmazie; 2010 Jan; 65(1):32-40. PubMed ID: 20187576
[TBL] [Abstract][Full Text] [Related]
39. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
Palmberger TF; Hombach J; Bernkop-Schnürch A
Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
[TBL] [Abstract][Full Text] [Related]
40. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]